Gene · 1942
Papers1,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. | Cells | 2023 | 36980256 | PubTator, text mining | PubMed |
| Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine. | Front Pharmacol | 2023 | 36959862 | PubTator, text mining | PubMed |
| Peripheral Circulating Exosomal-miRNAs Potentially Mediate the Sensitivity to Interferon Treatment in Chronic Hepatitis B Virus Patients. | Viral Immunol | 2023 | 36944116 | PubTator, text mining | PubMed |
| Genetic susceptibility to severe COVID-19. | Infect Genet Evol | 2023 | 36934789 | PubTator, text mining | PubMed |
| Influence of Genetic Variations in miRNA and Genes Encoding Proteins in the miRNA Synthesis Complex on Toxicity of the Treatment of Pediatric B-Cell ALL in the Brazilian Amazon. | Int J Mol Sci | 2023 | 36901860 | PubTator, text mining | PubMed |
| Plasma gelsolin levels are associated with diabetes, sex, race, and poverty. | J Transl Med | 2023 | 36899335 | PubTator, text mining | PubMed |
| Stigmasterol protects human brain microvessel endothelial cells against ischemia-reperfusion injury through suppressing EPHA2 phosphorylation. | Chin J Nat Med | 2023 | 36871980 | PubTator, text mining | PubMed |
| 3PNMF-MKL: A non-negative matrix factorization-based multiple kernel learning method for multi-modal data integration and its application to gene signature detection. | Front Genet | 2023 | 36865387 | PubTator, text mining | PubMed |
| Investigation of the Pathogenic Mechanism of Ciprofloxacin in Aortic Aneurysm and Dissection by an Integrated Proteomics and Network Pharmacology Strategy. | J Clin Med | 2023 | 36835806 | PubTator, text mining | PubMed |
The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling. | Int J Mol Sci | 2023 | 36835041 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Aging: An Emerging Hallmark? | Cells | 2023 | 36831194 | PubTator, text mining | PubMed |
| Eph Receptors in Cancer. | Biomedicines | 2023 | 36830852 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. | Nat Commun | 2023 | 36828832 | PubTator, text mining | PubMed |
| Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma. | World J Gastroenterol | 2023 | 36816628 | PubTator, text mining | PubMed |
| Physiological hypoxia improves growth and functional differentiation of human intestinal epithelial organoids. | Front Immunol | 2023 | 36793710 | PubTator, text mining | PubMed |
| Regulon active landscape reveals cell development and functional state changes of human primary osteoblasts in vivo. | Hum Genomics | 2023 | 36793138 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. | Int J Mol Sci | 2023 | 36769332 | PubTator, text mining | PubMed |
| From the Catastrophic Objective Irreproducibility of Cancer Research and Unavoidable Failures of Molecular Targeted Therapies to the Sparkling Hope of Supramolecular Targeted Strategies. | Int J Mol Sci | 2023 | 36769134 | PubTator, text mining | PubMed |
| Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics. | Int J Mol Sci | 2023 | 36768732 | PubTator, text mining | PubMed |
| Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling. | J Transl Med | 2023 | 36759828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1942/papers?page=9